Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Apr;115(4):740-744.
doi: 10.1097/AOG.0b013e3181d43ae4.

Gestrinone compared with mifepristone for emergency contraception: a randomized controlled trial

Shangchun Wu  1 , Jing Dong, Jie Cong, Cuiping Wang, Helena VonHertzen, Emily M Godfrey
Affiliations
Randomized Controlled Trial

Gestrinone compared with mifepristone for emergency contraception: a randomized controlled trial

Shangchun Wu et al. Obstet Gynecol. 2010 Apr.

Abstract

Objective: To compare the efficacy of gestrinone with that of mifepristone for emergency contraception.

Methods: A randomized double-blind trial was conducted in five family-planning clinics in China. We randomly assigned 998 healthy women with regular menstrual cycles and negative urine pregnancy tests who were requesting emergency contraception up to 72 hours after unprotected coitus to receive single-dose 10 mg gestrinone (n=499) or 10 mg mifepristone (n=499). We monitored them to 7 days after the expected first day of their next menstrual period. The study was powered to detect a 5% failure rate between the two regimens.

Results: The treatment groups did not differ significantly; posttreatment pregnancy rates were 2.4% in the gestrinone group compared with 1.8% in the mifepristone group (P=.51). The majority of women menstruated the first day of expected menses, and groups did not differ regarding side effects.

Conclusion: The effectiveness of 10 mg gestrinone is not significantly different from 10 mg mifepristone as an emergency contraceptive method.

Clinical trial registration: ISRCTN Register, isrctn.org, ISRCTN87842530.

Level of evidence: I.

PubMed Disclaimer

References

    1. von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360:1803–10.
    1. Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992;327:1041–4.
    1. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1999;353:697–702.
    1. Markiewicz L, Hochberg RB, Gurpide E. Intrinsic estrogenicity of some progestagenic drugs. J Steroid Biochem Mol Biol 1992;41:53–8.
    1. Verma U, Laumas KR. Screening of anti-progestins using in vitro human uterine progesterone receptor assay system. J Steroid Biochem 1981;14:733–40.

Publication types

Associated data